The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response
Invasive nontyphoidal Salmonella (NTS), including Salmonella typhimurium (STm), are major yet poorly-recognized killers of infants in sub-Saharan Africa. Death in these children is usually associated with bacteremia, commonly in the absence of gastrointestinal symptoms. Evidence from humans and animal studies suggest that severe infection and bacteremia occur when specific Ab is lacking. Understanding how Ab responses to Salmonella are regulated will help develop vaccines against these devastating infections. STm induces atypical Ab responses characterized by prominent, accelerated, extrafollicular T-independent (TI) Ab against a range of surface antigens. These responses develop without concomitant germinal centers, which only appear as infection resolves. Here, we show STm rapidly induces a population of TI B220 ؉ CD5 ؊ B1b cells during infection and TI Ab from B1b cells targets the outer membrane protein (Omp) porins OmpC, OmpD and OmpF but not flagellin. When porins are used as immunogens they can ablate bacteremia and provide equivalent protection against STm as killed bacterial vaccine and this is wholly B celldependent. Furthermore Ab from porin-immunized chimeras, that have B1b cells, is sufficient to impair infection. Infecting with porindeficient bacteria identifies OmpD, a protein absent from Salmonella Typhi, as a key target of Ab in these infections. This work broadens the recognized repertoire of TI protein antigens and highlights the importance of Ab from different B cell subsets in controlling STm infection. OmpD is a strong candidate vaccine target and may, in part, explain the lack of cross-protection between Salmonella Typhi and STm infections. primarily the serovars Typhimurium and Enteritidis) have a staggering impact on human health in infants and HIV ϩ adults, particularly in sub-Saharan Africa. In HIV Ϫ infants, the burden of NTS is greatest between 6 mo and 3 years and gastrointestinal symptoms are apparent in Ͻ50% of cases indicating NTS disease in Africa may be different to that in the West. Bacteremia is a strong correlate of disease severity and mortality in bacteremic children who reach clinic can be nearly 25%. Thus, restricting bacteremia may be pivotal to control these infections (1, 2) .
The requirements for effective immunity to Salmonella depend on the stage of infection. Effective clearance of primary infection requires persistent Th1 T cell responses, whereas at this stage Ab limits bacteremia (3, 4) . It is significant that although individuals who lack components of the IL-12 or IL-23 signaling pathways are more susceptible to invasive NTS disease they can still generate serum anti-Salmonella IgG (5) . Furthermore, these children do not die from NTS infection, are frequently without bacteremia, and do not commonly appear with chronic NTS infection within their first 2 years of life (6) .
The peak risk of disseminated NTS infection of between 6 and 24 mo supports a role for Ab against NTS because this coincides with loss of maternal Ab but before active humoral immunity is acquired (7) . Because vaccination of adults with isolated capsular polysaccharide (a wholly TI antigen), induces protective serum IgG against typhoid but poor mucosal responses (8) , it implies that serum Ab is sufficient to protect against typhoid and so may protect against NTS too.
We recently reported that STm induces an atypical Ab response with rapid and massive extrafollicular plasma cell responses decoupled from parallel induction of germinal centers (4) . The induction of this response is not T cell mediated although switching to the Th1 isotype IgG2a is T-dependent. Our studies identified STm Omp as early targets of switched Ab in this response. These contain many proteins including the related porins OmpC, OmpD, and OmpF, which are of a similar Mr (Ϸ40 kDa). OmpR regulates OmpC and OmpF expression but not OmpD (9) . Salmonella Typhi (ST) lack OmpD although it is found in all other Salmonella serovars examined (10) . Purified porins from ST induce an atypically long-lived Ab response, which contrasts to the gradually declining responses frequently observed after immunization with alum-precipitated proteins (11) .
Here, we show that porins and live STm induce B1b cells in a TI manner, whereas flagellin does not. A single immunization with porins from STm, but not ST, could moderate infection with virulent and attenuated STm. Ab to OmpD was important because porin immunization did moderate infection with bacteria lacking OmpC and OmpF but not bacteria lacking OmpD. Therefore, protein antigens from STm can induce TI antibodies via B1b cells and OmpD may be a candidate for a subunit vaccine against systemic NTS infection. We suggest that Ab-mediated vaccines, although unlikely to result in sterilizing immunity, can restrict the devastating impact of NTS infections.
Results

Salmonella Induce a Rapid TI Plasma Cell Response Against Selective
Antigens. Previous studies show that Salmonella induces a rapid and extensive Ab response (4) . Major targets of the early, switched response are Omp but not LPS or the flagellar protein, FliC. The rapid induction of this response suggested a TI element. To dissect this further, we infected mice lacking all T cells (TCR␤␦-deficient mice) with attenuated STm. Infection resulted in a large increase in CD138ϩ plasmacytoid cells by day 4 paralleled by a rapid induction of STm-specific serum IgM (Fig. 1A) . Detailed analysis revealed a strong induction of Ab to LPS and Omp, but a less marked response to FliC ( Fig. 1 A) . We focused on the TI response to Omp by examining the response to a highly pure porin preparation from STm containing OmpC and OmpD and some OmpF ( Fig. 1B and Materials and Methods). Analyses (Fig. 1B) showed that purified porins, predominantly formed ␤-strands, were heat-modifiable consistent with folded porins, and were oligomeric with oligomers typically 120-240 kDa thus suggesting a trimeric or hexameric configuration. Therefore, the porins adopt a natively folded oligomeric state consistent with their normal conformation in the outer membrane. ELISA and immunoblotting of sera from immunized T cell-deficient mice indicated that porins induced antigen-specific IgM (Fig. 1C) . In contrast anti-porin Ab was only a minor component of the natural Ab pool, because nonimmune sera (at 1:50) reacted with nonporin but not porin proteins. Thus, IgM Ab was induced specifically to STm porins in the absence of T cell help.
Porin-Induced Impairment of STm Infection Is Mediated Through B
Cells. It was then assessed whether Ab to purified porins could impair STm infection. WT mice were immunized with porins or heat-killed bacteria [HK, an established vaccine (8) ] and challenged 35 days later. Both immunogens conferred comparable benefit, reducing splenic bacterial burdens by 2-3 logs ( Fig. 2A ). To assess the role of B cells WT mice and B cell-deficient mice (IgH Ϫ/Ϫ mice) were immunized with porins and infected after 35 days. Immunized B cell-deficient mice had similar bacterial numbers as nonimmunized mice (Fig. 2B ). In contrast, opsonization of bacteria with complement-inactivated sera from porin-immunized T celldeficient mice reduced infection in these mice. Because the effects of porin immunization were B cell-mediated and TI we assessed whether switched Ab conferred additional benefit over IgM. To test this WT, CD28-deficient and T cell-deficient mice were immunized with porins and infected 35 days later. Although porin-specific IgM was induced in all groups after infection ( Fig. 2C ), porin-specific IgG was largely undetectable in T cell-deficient mice. Bacterial burdens were 10-fold greater in CD28-deficient animals and 40-fold greater in T cell-deficient mice. Because porin immunization was only effective in the presence of B cells and all groups of naïve animals had similar bacterial numbers 5 days after infection these data suggest that Ն90% of the benefit was IgG mediated (Fig. 2C) . Because bacteremia is a marker of severity the blood bacterial burden of nonimmunized and porin immunized animals was assessed. On day 5 of infection in nonporin-primed mice the median bacteremia was 6.0 ϫ 10 3 bacteria/mL whereas after immunization no bacteria were detected in blood ( Fig. 2D ). Thus, porin immunization is effective at eliminating bacteremia.
We next assessed how anti-porin Ab moderates infection to virulent STm strain SL1344. A single porin-immunization reduced splenic and liver bacterial numbers 4 days after infection by 20-and 40-fold respectively; a second porin immunization reduced this by 1,700-and 400-fold respectively ( Fig. 2E ). In these experiments, the reduction in bacterial numbers after porin immunization may prolong survival but would not prevent death. Last, we examined whether LPS from STm or porins from ST could provide similar benefits. Mice were immunized with highly pure STm LPS or with ST porins and infected 35 days later. Neither pure LPS nor ST porins conferred any benefit ( Fig. 2F ). This was surprising considering the high degree of identity between OmpC and OmpF from these 2 serovars. This suggests responses to the third STm porin, OmpD, may be important during NTS infection.
Ab to OmpD Is Sufficient to Impair STm Infection. It was then tested whether Ab to OmpD could account for the differing results observed after immunization with STm or ST porins. Mice were immunized with porins and infected with either STm or STm lacking OmpD. Bacterial numbers were similar in the spleen and livers of naïve and immunized mice after infection with OmpDdeficient STm but immunization offered significant protection against bacteraemia (Fig. 3A ). This impaired protection correlated with IgM Ab from porin-immunized mice failing to bind to the porin fraction from OmpD-deficient STm (Fig. 3A) . In contrast after porin immunization and infection with OmpRdeficient bacteria (lacking OmpC and OmpF but not OmpD) bacterial numbers were reduced, bacteremia was not measurable and binding of IgM Ab from porin-immunized mice to the porin fraction from OmpR-deficient STm was evident ( Fig. 3B ). This indicates that OmpD is an important target of Ab to STm and Ab to OmpD alone is sufficient to impair STm infection.
Porins and STm Induce a Population of Peritoneal B Cells with a B1b
Phenotype. The results above show the effectiveness of porin immunization depends on B cells and these responses are induced in the absence of T cells. Thus, we assessed whether TI B1 cells were recruited against porins. WT mice were immunized and peritoneal responses assessed 4 days later, using 7 color flow cytometry. CD19 ϩ and IgM ϩ lymphocytes were gated for low/ negative CD21 and CD23 expression and these examined for CD5 and B220 expression. Finally, CD11b expression on the B220 ϩ CD5 Ϫ population was assessed. Porin immunized mice, compared with nonimmunized mice, showed a significant induction of B cells with characteristics of B1b cells, being CD19 ϩ and IgM ϩ , B220 int but CD5 Ϫ with low CD21 and CD23 expression ( Fig. 4A ). B1b cells were also significantly induced by live STm and purified LPS but not HK STm, FliC, or OVA ( Fig. 4A , OVA, and data not shown). CD11b expression was variable between the groups. CD11b Ϫ B1b cells have been reported previously, at similar proportions to those described here, and have the potential to become CD11b ϩ after transfer into lymphopenic recipients (12) . The T-independence of this B1b induction was shown by giving porins or STm to TCR␤␦deficient mice (Fig. 4B) . These experiments showed a significant induction of B1b cells but also confirmed the differential expression of CD11b on B1b cells induced by porins or STm. Thus, STm and porins induce a peritoneal population of TI B1b B cells.
Anti-Porin Ab from B1b B Cells Is Sufficient to Impair Infection. To test whether Ab produced by B1b cells responding to porins could limit STm infection chimeric mice were generated that have B1b cells but lack B1a cells and have few B2 cells (13) . Peritoneal B220 ϩ CD5 Ϫ cells were sorted from 4 day porin-immunized WT mice and 2 ϫ 10 5 sorted cells were transferred into B celldeficient mice (Fig. 5A ). This population does include B2 follicular cells but these cells do not expand after transfer into lymphopenic mice (14) and thus only contribute a small proportion of the final B cell population after B1b cell expansion. Nonimmunized B1b chimeras could produce natural IgM antibody but this did not react to porins (Fig. 5A ). Forty-eight hours after cell transfer B1b recipients and B cell-deficient mice that did not receive cells were immunized with porins. After 20 days the success of immunization was confirmed by measuring antiporin IgM from the immunized chimeras. The next day mice were infected with 5 ϫ 10 5 STm and bacterial burdens and serum Ab assessed 5 days later. Only mice that had peritoneal B cells and anti-porin Ab could impair STm infection ( Fig. 5B ). Porin-immunized B cell-deficient mice that did not receive B1b cells had bacterial numbers equivalent to nonimmunized mice. After infection peritoneal B cells in B1b chimeras were IgM ϩ , and approximately half were also CD11b ϩ (Fig. 5B) . Therefore, Ab from B1b cells is sufficient to limit infection.
Discussion
This work has 3 major findings: First, Ab to OmpD can reduce STm infection. Second, porins and viable STm but not FliC, induce a TI B1b cell response. Finally porin-induced Ab from these cells impairs STm infection. There has been controversy about the role of LPS in responses to porins, in part because LPS may associate with some porin trimers (e.g., OmpF). In the current study LPS was unlikely to be a potential confounder because purified porins had low levels of LPS and immunization with highly pure STm LPS did not moderate infection (Fig. 2F ). Furthermore, infecting porin-immunized mice with LPSsufficient, OmpD-deficient STm resulted in a diminution in Ab binding to the cell wall and a failure to reduce bacterial infection.
OmpD is a trimeric porin with homology to OmpF and OmpC (9, 15) whose expression is enhanced by anaerobiosis and suppressed by low pH, whereas OmpF and OmpC expression is sensitive to changes in osmolarity (16) . OmpD has an unclear role in infection whereas loss of OmpR is attenuating (17, 18) . Studies have identified a lack of cross-reactivity between surface binding mAb to these 3 porins (19) . Indeed, for OmpD many antibodies only recognize the protein in trimeric but not monomeric form (19) suggesting exposed regions are under selective immune pressure. Multiple studies have assessed the potential of porins as vaccines, often with conflicting results, but few have specifically examined OmpD, presumably because of its absence in ST (e.g., ref. 20) . Some studies that failed to show benefit from porins involved passive transfer of anti-porin antibodies (e.g. ref. 21) , which may not have sufficiently covered the porin epitope repertoire. The current study shows that the natural response to OmpD in STm is sufficient to achieve marked reductions in bacterial numbers, although its effects may be potentiated by other factors, such as natural antibody. The importance of antibody to OmpD does not preclude roles for antibody to OmpF or OmpC, because other reasons may account for its minor role here, such as the amount of OmpF and OmpC in the preparations, or their expression in STm at different growth stages.
The failure to achieve sterile immunity after porin immunization may not be an impediment to reducing disease; for in humans multiple lines of evidence suggest sterilizing immunity is not essential to achieve clinical benefit. In infants in sub-Saharan Africa systemic STm infection can lead to fatal bacteremia (2). The peak incidence of this, between 6 and 24 months, coincides with the loss of passively acquired maternal IgG and before protection from active immunity. Nearly all children have Ab by 3 years, indicating previous exposure, indeed Ab correlates with decreased risk of bacteremia (7) . Similarly, some patients with defective IL-12/23 signaling lacking a clinical history of Salmonella infection have anti-Salmonella IgG (5) . This suggests IL-12/23-independent mechanisms may exist for coping with NTS infections. Therefore, the sterilizing immunity necessary to protect against infection with virulent STm SL1344 in susceptible strains of mice may overstate the degree of immunity required to protect against NTS or typhoid in humans. Indeed in vaccinated humans the protection vaccines confer can be overwhelmed if the infecting dose is sufficiently high (22) . Thus, although it is unlikely Ab can confer sterilizing immunity it can diminish bacterial numbers at the time of infection and the extracellular dissemination of infection that results in bacteremia. Therefore, even modest reductions in infecting NTS numbers may result in substantial clinical benefits.
TI Ab to protein antigens has been described for the glycoprotein of vesicular stomatitis virus (23) and complement factor H-binding protein from the bacterial pathogen Borrelia (24) . For the latter, self-renewing B1b cells play important roles (25) as they do in pneumococcal infections (26) . This suggests B1b cells may play significant roles in a range of infections and reflects our ever increasing understanding of the diversity of B cell responses to pathogens (27) . In the current study all benefits from porin immunization were B cell mediated and Ab from B1b cells was sufficient to impair infection (Figs. 2B and 5 ). The induction of B1b cells to porins and STm may also explain, at least in part, why the early nonswitched extrafollicular plasma cell response occurs similarly in WT and T cell-deficient/impaired mice whereas functional T cell responses are required for extrafollicular responses against model protein antigens (28) . The massive extent and rapid induction of the extrafollicular Ab response to STm suggests antigen availability is not limiting (4) and the B1b cell repertoire may be broader than originally thought.
Responses to typhoid Vi antigen may involve B1b cells and so immunization with STm porins or Vi antigen may act similarly in their respective infections. However, Ab to purified Vi antigen in humans is wholly TI and induces poor mucosal Ab (8) but porins can induce good T-dependent responses (29) . It has long been appreciated that infants and the elderly have impaired responses to TI-2 antigens, such as capsular polysaccharide. It is tempting to speculate, as others have, that deficiencies in B1b cells in children are responsible for susceptibility to encapsulated bacteria (30) . Interestingly, whereas responses to TI-2 antigens involve 2 sets of B cells, B1b cells, and marginal zone (MZ) B cells, mice deficient in the tyrosine kinase pyk2 lack MZ but not B1b B cells yet induce potent IgM and IgG responses to the TI-2 antigen TNP-Ficoll (31) . In addition, RAG-1 mice reconstituted with as few as 10 5 B1b cells and lacking other B cell types mount strong and persistent Ab responses to NP-Ficoll (13) . This suggests that responses to TI antigens are likely to be of sufficient evolutionary importance that multiple cell types are involved.
Materials and Methods
Mice, Bacterial Strains, Immunogens, and Biophysical Assessments. Animal studies had ethical and Home Office approval. WT and gene-deficient mice are reported elsewhere except for TCR␤␦ Ϫ/Ϫ mice, which were from Jax (4). Mice were age (6 -12 weeks) and sex-matched. STm SL1344 is a virulent strain and SL3261 is an AroA Ϫ attenuated strain (described in ref. 4) . OmpD Ϫ STm strain RAK126 was made by transferring the Tn10::tet r insertion in ompD of STm strain BRD455 (17, 18) by P22 generalized transduction into SL3261. The OmpR Ϫ STm strain RAK83 was constructed using red recombinase (32) . Briefly, aph, encoding kanamycin resistance, was amplified using primers (5ЈGGATCGTCTGCTGACCCGTGAATCTT-TCCATCTCATGGGTGTAGGCTGGAGCTGCTTC3Ј and 5ЈGTCTGAATATAACGCG-GATGTGCCGGATCTTCTTCCACATTCCGGGGATCCGTCGACC3Ј) that contained sequence flanking the deletion target and electrotransformed into STm SL3261 expressing -red recombinase. The ⌬ompR::aph was transferred to STm SL3261 by P22 transduction. The genotype of strains was confirmed by PCR and PAGE.
Total Omp preparations were made by 2% (vol/vol) Triton X-100 extraction (4). Purified porins from ST (strain ATCC 9993) and STm (strain ATCC 14028) were generated (29) by repeated extraction with SDS and separation by FPLC on a Sephacryl S-200 column before dialysis against PBS/0.1% (wt/vol) SDS. Limulus amebocyte lysate assay showed LPS contamination at 0.06 EU/480 g porins. Protein identity was confirmed by trypsin digest and mass spectrometry. TLRgrade STm LPS was purchased (Axxora ALX-581-011-L002). Flagellin was made as described in ref. 4 . OVA, Imject grade, was from Thermo Scientific.
For sedimentation velocity and CD measurements protein was dialyzed against PBS, 0.1% SDS, pH 7.4, at 20°C. Far UV CD measurements were performed on a Jasco J-715 spectropolarimeter with a 1-mm path length cell, 2-nm bandwidth, 1-nm increments, 100 nm/min scanning speed, 2-s response time, and continuous scanning mode. 20 scans were averaged and the spectrum corrected for buffer contribution. Data were interpreted using standard methods described in ref. 33 .
Analytical ultracentrifugation (AUC) sedimentation velocity was performed in a Beckman Coulter proteome XL-I protein characterization system. Protein and buffer reference were centrifuged at 20,000 rpm in a Ti-50 rotor and analyzed using Sedfit (34) .
Immunization and Infection of Mice and Opsonization Experiments.
Mice were immunized i.p. with 20 g of proteins or LPS in PBS for 35 days unless stated otherwise. HK bacteria (10 7 per mouse) were heated for 1 h at 65°C. Bacteria were from cultures with an OD 600 of Ͼ1.0. Mice were infected i.p. with attenuated bacteria at 5 ϫ 10 5 or 5 ϫ 10 6 per animal as described in the text. Mice were infected i.p. with 3 ϫ 10 3 WT SL1344 bacteria. Bacterial numbers were determined by direct culturing (4) . Experiments with mice and opsonized bacteria were performed as described previously except sera were from naïve or immunized TCR␤␦ Ϫ/Ϫ mice (4). A single serum was used per mouse and all sera were heat-inactivated at 56°C for 0.5 h. Bacteria (2.5 ϫ 10 6 /mL) and sera (1:100) were mixed for 0.5 h before infection and bacterial viability and lack of agglutination confirmed.
Immunohistology, ELISA, and Immunoblotting. Immunohistology was performed on frozen sections as described in ref. 4 . CD138 ϩ cells were detected using rat anti-mouse CD138 (BD), biotinylated sheep anti-rat and streptavidin-ABComplex alkaline phosphatase (AP) (DakoCytomation) (4) . Cells per square millimeter were calculated using a point-counting technique (35) . ELISA was performed as previously described to detect Ab to STm, LPS, FliC, and OMP (4). Antigen was used at 5 g/mL and primary antibodies and AP-linked goat anti-mouse isotype antibodies used to identify isotypes. To detect serum IgM posttransfer, wells were coated with Rat anti-mouse IgM and bound IgM detected as above. For immunoblotting, proteins were transferred onto PVDF membrane and endogenous HRP eliminated using SG substrate (Vector Laboratories). Sera were added overnight (1:50 for naïve and 1:100 Ϫ500 for immunized sera) and signal detected with HRP-conjugated goat anti-mouse IgM and Supersignal Chemiluminescense (Thermo Scientific).
FACS Analysis and Cell Sorting.
Cells were stained with one or more of these anti-mouse mAb: IgMFITC (eB121-15F9), IgMPE-Cy7 (11/41), CD19APC-Cy7 (1D3), CD3 PerCPcy5 (145-2C11), CD11c APC (N418), CD11b PE (M1/70), CD5 PE-Cy5 (53-7.3 or Ly-1), B220APC (RA3-6B2) or B220Pacific Blue (RA3-6B2), CD21FITC (7G6), and CD23PE (B3B4) (All from E-Bioscience) and assessed on a FACScalibur or CyAn ADP Flow Cytometer and analyzed using FlowJo 8.8.3. (TreeStar). B1b chimeras were generated as described in ref. 13 , with modifications. WT mice were immunized with porins for 4 days and B1b cells (B220 int CD5 Ϫ ) sorted. Cells (2 ϫ 10 5 ) were transferred into IgH Ϫ/Ϫ mice and 3 days later chimeras immunized i.p. with 20 g of porins. Transfer success was confirmed by detecting IgM and anti-porin Ab 20 days later before challenge with STm. Statistics. Statistics were calculated using the Mann-Whitney test; significance was accepted at P Յ 0.05 (4) .
